CMS Price Negotiation Could Tackle High-Cost Drugs, Economists Suggest

Medicare should consider negotiating prices for drugs that are priced high for Part D relative to other selected payers, Johns Hopkins University Professor of Health Policy and Management Gerald Anderson advocated at a Jan. 11 Senate Finance Committee hearing